94 related articles for article (PubMed ID: 11460465)
1. Insight from studies with recombinant fibrinogens.
Lord ST; Gorkun OV
Ann N Y Acad Sci; 2001; 936():101-16. PubMed ID: 11460465
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of recombinant Bbeta15C and Bbeta15A fibrinogens demonstrates that Bbeta15G residue plays important roles in FPB release and in lateral aggregation of protofibrils.
Hirota-Kawadobora M; Kani S; Terasawa F; Fujihara N; Yamauchi K; Tozuka M; Okumura N
J Thromb Haemost; 2005 May; 3(5):983-90. PubMed ID: 15869595
[TBL] [Abstract][Full Text] [Related]
3. Recombinant fibrinogen studies reveal that thrombin specificity dictates order of fibrinopeptide release.
Mullin JL; Gorkun OV; Binnie CG; Lord ST
J Biol Chem; 2000 Aug; 275(33):25239-46. PubMed ID: 10837485
[TBL] [Abstract][Full Text] [Related]
4. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
Soya K; Terasawa F; Okumura N
Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
[TBL] [Abstract][Full Text] [Related]
5. Strategy for recombinant multichain protein synthesis: fibrinogen B beta-chain variants as thrombin substrates.
Lord ST; Strickland E; Jayjock E
Biochemistry; 1996 Feb; 35(7):2342-8. PubMed ID: 8652575
[TBL] [Abstract][Full Text] [Related]
6. Analysis of A alpha 251 fibrinogen: the alpha C domain has a role in polymerization, albeit more subtle than anticipated from the analogous proteolytic fragment X.
Gorkun OV; Henschen-Edman AH; Ping LF; Lord ST
Biochemistry; 1998 Nov; 37(44):15434-41. PubMed ID: 9799505
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.
Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST
Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918
[TBL] [Abstract][Full Text] [Related]
8. Analysis of engineered fibrinogen variants suggests that an additional site mediates platelet aggregation and that "B-b" interactions have a role in protofibril formation.
Lounes KC; Ping L; Gorkun OV; Lord ST
Biochemistry; 2002 Apr; 41(16):5291-9. PubMed ID: 11955079
[TBL] [Abstract][Full Text] [Related]
9. Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization.
Ruf W; Bender A; Lane DA; Preissner KT; Selmayr E; Müller-Berghaus G
Biochim Biophys Acta; 1988 May; 965(2-3):169-75. PubMed ID: 3365451
[TBL] [Abstract][Full Text] [Related]
10. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
Rooney MM; Mullin JL; Lord ST
Biochemistry; 1998 Sep; 37(39):13704-9. PubMed ID: 9753458
[TBL] [Abstract][Full Text] [Related]
11. Severely impaired polymerization of recombinant fibrinogen gamma-364 Asp --> His, the substitution discovered in a heterozygous individual.
Okumura N; Gorkun OV; Lord ST
J Biol Chem; 1997 Nov; 272(47):29596-601. PubMed ID: 9368024
[TBL] [Abstract][Full Text] [Related]
12. Decreased lateral aggregation of a variant recombinant fibrinogen provides insight into the polymerization mechanism.
Mullin JL; Gorkun OV; Lord ST
Biochemistry; 2000 Aug; 39(32):9843-9. PubMed ID: 10933802
[TBL] [Abstract][Full Text] [Related]
13. Comparison of thrombin-catalyzed fibrin polymerization and factor XIIIa-catalyzed cross-linking of fibrin among three recombinant variant fibrinogens, gamma 275C, gamma 275H, and gamma 275A.
Hirota-Kawadobora M; Terasawa F; Suzuki T; Tozuka M; Sano K; Okumura N
J Thromb Haemost; 2004 Aug; 2(8):1359-67. PubMed ID: 15304042
[TBL] [Abstract][Full Text] [Related]
14. γD318Y fibrinogen shows no fibrin polymerization due to defective "A-a" and "B-b" interactions, whereas that of γK321E fibrinogen is nearly normal.
Kamijo T; Mukai S; Taira C; Higuchi Y; Okumura N
Thromb Res; 2019 Oct; 182():150-158. PubMed ID: 31484085
[TBL] [Abstract][Full Text] [Related]
15. Polymerization site a function dependence on structural integrity of its nearby calcium binding site.
Lounes KC; Okumura N; Hogan KA; Ping L; Lord ST
Ann N Y Acad Sci; 2001; 936():205-9. PubMed ID: 11460475
[TBL] [Abstract][Full Text] [Related]
16. Recombinant BbetaArg14His fibrinogen implies participation of N-terminus of Bbeta chain in desA fibrin polymerization.
Moen JL; Gorkun OV; Weisel JW; Lord ST
Blood; 2003 Oct; 102(7):2466-71. PubMed ID: 12805063
[TBL] [Abstract][Full Text] [Related]
17. Characterization of purified recombinant fibrinogen: partial phosphorylation of fibrinopeptide A.
Binnie CG; Hettasch JM; Strickland E; Lord ST
Biochemistry; 1993 Jan; 32(1):107-13. PubMed ID: 8418831
[TBL] [Abstract][Full Text] [Related]
18. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.
Ikeda M; Kobayashi T; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N
Thromb Res; 2014 Aug; 134(2):518-25. PubMed ID: 24968960
[TBL] [Abstract][Full Text] [Related]
19. B beta Glu397 and B beta Asp398 but not B beta Asp432 are required for "B:b" interactions.
Kostelansky MS; Bolliger-Stucki B; Betts L; Gorkun OV; Lord ST
Biochemistry; 2004 Mar; 43(9):2465-74. PubMed ID: 14992584
[TBL] [Abstract][Full Text] [Related]
20. Recombinant variant fibrinogens substituted at residues gamma326Cys and gamma339Cys demonstrated markedly impaired secretion of assembled fibrinogen.
Haneishi A; Terasawa F; Fujihara N; Yamauchi K; Okumura N; Katsuyama T
Thromb Res; 2009 Jul; 124(3):368-72. PubMed ID: 19419756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
